New Cardiovascular Biomarkers in Ischemic Heart Disease-GDF-15, A Probable Predictor for Ejection Fraction.

Daniel DalosGeorg SpinkaMatthias SchneiderBernhard WernlyVera PaarUta HoppeBrigitte LitschauerJeanette Strametz-JuranekMichael Sponder

Published in: Journal of clinical medicine (2019)

Biomarkers such as suPAR, GDF-15, H-FABP, and sST2 are increased in CAD patients, especially in highly impaired EF. Besides NT-proBNP as a well-known marker for risk prediction, GDF-15 may be an additional tool for diagnosis and clinical follow-up.

Keyphrases

ejection fraction
aortic stenosis
end stage renal disease
chronic kidney disease
heart failure
patient reported outcomes
prognostic factors
binding protein
transcatheter aortic valve replacement
aortic valve